NEPT - ネプチュ―ン・テクノロジ―ズ・アンド・バイオリソ―シズ (Neptune Wellness Solutions Inc.) ネプチュ―ン・テクノロジ―ズ・アンド・バイオリソ―シズ

 NEPTのチャート


 NEPTの企業情報

symbol NEPT
会社名 Neptune Technologies_Bioresources Inc (ネプチュ―ン・テクノロジ―ズ・アンド・バイオリソ―シズ)
分野(sector) Health Care   ヘルスケア
産業(industry) Major Pharmaceuticals  
業種    一般消費財(Consumer Products)
概要 事業概要 --   ネプチュ―ン・テクノロジ―ズ・アンド・バイオリソ―シズは、カナダの栄養医薬品会社。栄養補助食品、機能性食品、化粧品の研究、開発、製造、販売に従事。植物や魚油によるオメガ3系脂肪酸とは異なる南極オキアミ(南極海に生息する甲殻類)から抽出した独自のオメガ3製品などを販売している。本社は、ケベック州ラバル。   Neptune Wellness Solutions specializes in the extraction, purification and formulation of health and wellness products. The Company has in excess of 100 customers across several verticals including legal cannabis and hemp, nutraceutical and consumer packaged goods. Neptune's wholly owned subsidiary, 9354-7537 Québec Inc., is licensed by Health Canada to process cannabis at its 50,000-square-foot facility located in Sherbrooke, Quebec. The Company also has a 24,000 square-foot facility located in North Carolina to process hemp biomass into extracts. Neptune brings decades of experience in the natural products sector to the legal cannabis and hemp industries. Leveraging its scientific and technological expertise, the Company sees applications for hemp-derived extracts in the U.S. beyond existing markets and product forms and into personal care and home care markets. Neptune's activities also include the development and commercialization of turnkey nutrition solutions and patented ingredients such as MaxSimil®, and a variety of marine and seed oils. Its head office is located in Laval, Quebec.
本社所在地 545 Promenade du Centropolis Suite 100 Laval Quebec H7T 0A3 CAN
代表者氏名
代表者役職名
電話番号
設立年月日 36069
市場名 NASDAQ Small Cap
ipoyear ―年
従業員数 61人
url www.neptunebiotech.com
nasdaq_url https://www.nasdaq.com/symbol/nept
adr_tso
EBITDA EBITDA ー
終値(lastsale) 4.31
時価総額(marketcap) 342726196.09
時価総額 時価総額 ―
売上高 売上高 --
企業価値(EV) 企業価値(EV) ー
当期純利益 当期純利益 --
決算概要 決算概要 --

 NEPTのテクニカル分析


 NEPTのニュース

   Neptune Wellness Solutions Inc Shares Close the Day 10.2% Higher - Daily Wrap  2021/05/13 22:30:00 Kwhen Finance
Neptune Wellness Solutions Inc (NEPT) shares closed today 10.2% higher than it did at the end of yesterday. The stock is currently down 23.7% year-to-date, down 53.5% over the past 12 months, and up 13.3% over the past five years. Today, the Dow Jones Industrial Average rose 1.1%, and the S&P 500 rose 1.5%. Trading Activity Shares traded as high as $1.31 and as low as $1.06 this week.Shares closed 7e+1% below its 52-week high and 1e+1% above its 52-week low.Trading volume this week was 22.2% higher than the 10-day average and 23.2% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.1. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price beats the S&P 500 Index today, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average today, lags it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector today, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Neptune Wellness Solutions Inc Shares Close in on 52-Week Low - Market Mover  2021/05/11 22:30:00 Kwhen Finance
Neptune Wellness Solutions Inc (NEPT) shares closed today at 0.9% above its 52 week low of $1.15, giving the company a market cap of $208M. The stock is currently down 19.2% year-to-date, down 47.3% over the past 12 months, and up 26.0% over the past five years. This week, the Dow Jones Industrial Average rose 0.4%, and the S&P 500 fell 0.3%. Trading Activity Trading volume this week was 26.5% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.0. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Neptune Wellness Solutions Inc. Shares Close the Week 20.6% Higher - Weekly Wrap  2021/03/12 22:30:00 Kwhen Finance
Neptune Wellness Solutions Inc. shares closed this week 20.6% higher than it did at the end of last week. The stock is currently up 9.0% year-to-date, up 40.5% over the past 12 months, and up 53.2% over the past five years. This week, the Dow Jones Industrial Average rose 4.1%, and the S&P 500 rose 2.7%. Trading Activity Shares traded as high as $1.70 and as low as $1.34 this week.Shares closed 5e+1% below its 52-week high and 8e+1% above its 52-week low.Trading volume this week was 17.1% lower than the 10-day average and 70.3% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.7. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price beats the S&P 500 Index this week, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, lags it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Neptune Wellness Solutions Inc. Shares Close the Week 30.0% Lower - Weekly Wrap  2021/02/19 22:30:00 Kwhen Finance
Neptune Wellness Solutions Inc. shares closed this week 30.0% lower than it did at the end of last week. The stock is currently up 25.6% year-to-date, up 5.9% over the past 12 months, and up 96.0% over the past five years. This week, the Dow Jones Industrial Average rose 0.2%, and the S&P 500 fell 0.7%. Trading Activity Shares traded as high as $2.90 and as low as $1.65 this week.Shares closed 5e+1% below its 52-week high and 1e+2% above its 52-week low.Trading volume this week was 28.9% lower than the 10-day average and 61.0% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.9. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price lags the S&P 500 Index this week, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price lags the Dow Jones Industrial Average this week, lags it on a 1-year basis, and lags it on a 5-year basis The company share price lags the performance of its peers in the Health Care industry sector this week, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Neptune Wellness Solutions Inc. Shares Close the Day 16.7% Higher - Daily Wrap  2021/02/19 22:30:00 Kwhen Finance
Neptune Wellness Solutions Inc. shares closed today 16.7% higher than it did at the end of yesterday. The stock is currently up 25.6% year-to-date, up 5.9% over the past 12 months, and up 96.0% over the past five years. Today, the Dow Jones Industrial Average fell 0.0%, and the S&P 500 fell 0.2%. Trading Activity Shares traded as high as $2.90 and as low as $1.65 this week.Shares closed 5e+1% below its 52-week high and 1e+2% above its 52-week low.Trading volume this week was 28.9% lower than the 10-day average and 61.0% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.9. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price beats the S&P 500 Index today, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average today, lags it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector today, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Earnings Preview: Neptune Technologies (NEPT) Q4 Earnings Expected to Decline  2020/06/03 16:30:07 Zacks Investment Research
Neptune Tech (NEPT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
   Neptune Technologies (NEPT) Reports Break-Even Earnings for Q3  2020/02/13 12:45:04 Zacks Investment Research
Neptune Tech (NEPT) delivered earnings and revenue surprises of 100.00% and -2.78%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
   The Week In Cannabis: Stocks Fall On Poor Earnings, More Americans Support Legalization  2019/11/15 22:12:28 Benzinga
Two-thirds of Americans say the use of marijuana should be legal, reflecting a considerable surge over the past decade.. Two-thirds of Americans say the use of marijuana should be legal, reflecting a steady increase over the past decade https://t.co/QoMXjiaUYk pic.twitter.com/V4vLqY3r9f — Pew Research Fact Tank (@FactTank) November 14, 2019 GW Pharmaceuticals PLC (NASDAQ: GWPH ) announced two of its medicines have been recommended by the U.K.’s National Institute for Health and Care Excellence to receive routine reimbursement from the National Health Service. Epidiolex, known as Epidyolex in Europe, and Sativex were approved by the NHS for the treatment of epilepsy and multiple sclerosis, respectively. These were probably the most upbeat news items in the cannabis and hemp world this week. The following companies disappointed analysts and investors with their quarterly results and/or guidance (see full coverage for all of these earnings reports in our Cannabis Earnings Portal ): Canopy Growth Corp (NYSE: CGC ) Neptune Wellness Solutions Inc.
   Neptune Wellness Falls On Higher Quarterly Net Loss, Announces Hemp-Derived CBD Deal  2019/11/11 15:41:19 Benzinga Feeds
Neptune Wellness Solutions Inc. (NASDAQ: NEPT ) (TSX: NEPT) reported second-quarter revenue of CA$6.51 million ($4.9 million) on Monday and announced a partnership with International Flavors & Fragrances Inc. (NYSE: IFF ). The second-quarter revenue of CA$6.51 million was lower than the CA$7.07 million in revenue posted in the same period of 2018. The company also posted a quarterly net loss of CA$20.78 million versus a net loss of CA$3.05 million in the corresponding quarter of the prior year. Its adjusted EBITDA was a loss of CA$4.58 million, which is by CA$3.35 million lower than in the second quarter of 2018. Neptune also noted recent milestones such as the acquisition of SugarLeaf assets, which included the CBD consumer brand Forest Remedies; and its entrance into a strategic partnership … Full story available on Benzinga.com
   Neptune Technologies (NEPT) Reports Q2 Loss, Lags Revenue Estimates  2019/11/11 13:25:02 Zacks Investment Research
Neptune Tech (NEPT) delivered earnings and revenue surprises of -325.00% and -23.16%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
   Earnings Preview: Neptune Technologies (NEPT) Q4 Earnings Expected to Decline  2020/06/03 16:30:07 Zacks Investment Research
Neptune Tech (NEPT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
   Neptune Technologies (NEPT) Reports Break-Even Earnings for Q3  2020/02/13 12:45:04 Zacks Investment Research
Neptune Tech (NEPT) delivered earnings and revenue surprises of 100.00% and -2.78%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
   The Week In Cannabis: Stocks Fall On Poor Earnings, More Americans Support Legalization  2019/11/15 22:12:28 Benzinga
Two-thirds of Americans say the use of marijuana should be legal, reflecting a considerable surge over the past decade.. Two-thirds of Americans say the use of marijuana should be legal, reflecting a steady increase over the past decade https://t.co/QoMXjiaUYk pic.twitter.com/V4vLqY3r9f — Pew Research Fact Tank (@FactTank) November 14, 2019 GW Pharmaceuticals PLC (NASDAQ: GWPH ) announced two of its medicines have been recommended by the U.K.’s National Institute for Health and Care Excellence to receive routine reimbursement from the National Health Service. Epidiolex, known as Epidyolex in Europe, and Sativex were approved by the NHS for the treatment of epilepsy and multiple sclerosis, respectively. These were probably the most upbeat news items in the cannabis and hemp world this week. The following companies disappointed analysts and investors with their quarterly results and/or guidance (see full coverage for all of these earnings reports in our Cannabis Earnings Portal ): Canopy Growth Corp (NYSE: CGC ) Neptune Wellness Solutions Inc.
   Neptune Wellness Falls On Higher Quarterly Net Loss, Announces Hemp-Derived CBD Deal  2019/11/11 15:41:19 Benzinga Feeds
Neptune Wellness Solutions Inc. (NASDAQ: NEPT ) (TSX: NEPT) reported second-quarter revenue of CA$6.51 million ($4.9 million) on Monday and announced a partnership with International Flavors & Fragrances Inc. (NYSE: IFF ). The second-quarter revenue of CA$6.51 million was lower than the CA$7.07 million in revenue posted in the same period of 2018. The company also posted a quarterly net loss of CA$20.78 million versus a net loss of CA$3.05 million in the corresponding quarter of the prior year. Its adjusted EBITDA was a loss of CA$4.58 million, which is by CA$3.35 million lower than in the second quarter of 2018. Neptune also noted recent milestones such as the acquisition of SugarLeaf assets, which included the CBD consumer brand Forest Remedies; and its entrance into a strategic partnership … Full story available on Benzinga.com
   Neptune Technologies (NEPT) Reports Q2 Loss, Lags Revenue Estimates  2019/11/11 13:25:02 Zacks Investment Research
Neptune Tech (NEPT) delivered earnings and revenue surprises of -325.00% and -23.16%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

 関連キーワード  (― 米国株 ネプチュ―ン・テクノロジ―ズ・アンド・バイオリソ―シズ NEPT Neptune Wellness Solutions Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)